picture of

Thought leadership paper outlines the real impact of increased transparency

The MCI Group's thought leadership paper focuses on the impact and effects of increasing transparency on the medical industry’s support of healthcare professionals and healthcare organisations

Recommended

Subscribers

Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +

New

ABPI responds to NICE/NHS England consultation on evaluating and funding new medicines

January 20, 2017

The Association of the British Pharmaceutical Industry (ABPI) has responded to the consultation ...

Regulatory | R and D | Finance

FDA issues guidance to prevent listeria

January 19, 2017

New US guidance from the FDA will help keep RTE foods free from bacterium Listeria monocytogene ...

North America | Regulatory

Incorporating quality by design (QbD) into pharmaceutical manufacturing

January 9, 2017

The pharmaceutical industry has always maintained a focus on quality; the risks are simply too ...

Regulatory | Manufacturing and Equipment

Improving patient adherence and enhancing lives

January 6, 2017

One of the key issues facing pharmaceutical providers today is the threat of counterfeit medica ...

Packaging | Regulatory

Top global pharma companies establish new industry standards group

January 15, 2017

Veeva Systems and six of the top 25 largest global pharmaceutical companies have announced the ...

Regulatory | Information Technology

The importance of level 3 applications and software

December 14, 2016

How to future-proof your serialisation solution

Packaging | Regulatory | Manufacturing and Equipment

PCI Clinical Services and Suvoda announce partnership for clinical trial IRT solutions

January 15, 2017

Leading clinical outsourcing services provider, PCI Clinical Services (PCI), has announced a pa ...

Regulatory | R and D | Finance

At the heart of it

December 13, 2016

Patient-centric drug development and clinical trial logistics

Regulatory | Drug Delivery

Shuwen Biotech receives EN ISO 13485 certification

January 13, 2017

Shuwen Biotech Co. Ltd, a China-based diagnostic company focused on licensing, developing and c ...

Regulatory | Asia | Measurement and Analysis

Supplying the one in a million

December 12, 2016

How has the onset of orphan drugs affected the supply chain?

Regulatory

In Brief